Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2011 by South Florida Veterans Affairs Foundation for Research and Education.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by:
South Florida Veterans Affairs Foundation for Research and Education
ClinicalTrials.gov Identifier:
NCT01417806
First received: August 15, 2011
Last updated: NA
Last verified: July 2011
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)